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Abstract
The hypothalamic–pituitary-gonadal (HPG) axis plays a crucial and integrative 
role in the mammalian endocrine regulation to maintain homeostasis. The HPG axis 
is primarily responsible for governing all the hormonal events related to reproduc-
tive activity. Endocrine-disrupting chemicals (EDCs) comprise a diverse group 
of naturally occurring and synthetic compounds that mimic and interfere with 
the endogenous chemical hormones. Epidemiological investigations have shown 
increasing evidence of altered development and detrimental effects on reproductive 
health during the past 50 years associated with endocrine disruptors affecting the 
HPG axis. The pleiotropic harmful effects of EDCs act through hormone-dependent 
downstream signaling pathways responsible for gonad development either through 
direct interaction with steroid hormone receptor or via epigenetic regulation. 
Hence, this chapter summarizes the biological plausibility of EDCs exposure and 
elucidates the mechanism of action underlying EDCs affecting the regulatory 
circuits of the mammalian HPG axis and reproductive function.
Keywords: endocrine disrupting chemicals, hypothalmic-pituitary-gonadal axis, 
reproduction, epigenetic, polycystic ovarian syndrome
1. Introduction
In the past decade, endocrine disruptor chemicals (EDCs) in human pathophysi-
ology have gained much more attention due to their ability to affect development 
and reproduction in humans and wildlife. In accordance with the US Environmental 
Protection Agency (EPA), EDCs can be defined as ‘exogenous agents that disrupt 
the hormone homeostasis by interfering with the synthesis, secretion, transport, 
metabolism, receptor binding or elimination of endogenous hormone [1–6]. EDCs 
comprise mainly heterogeneous compounds, including synthetic (chemical) and 
natural (plant products such as isoflavones) responsible for disrupting the hormone 
system. Endocrine disruptors may be found easily in almost every product used in 
our daily life, including detergents, plastic bottles, food, toys, pesticides, insecti-
cides, and flame retardants. The criteria proposed by the European Commission for 
being in the process of defining any compound as EDCs should at least exhibit three 
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characters: (1) an endocrine activity, (2) an adverse or deleterious endocrine medi-
ated effect in the exposed subject or its progeny or subpopulations (3) a plausible 
cause-effect relationship between the two [7, 8]. Most of the EDCs interfere with 
the endocrine system by binding the hormonal receptor or regulating genomic 
expression. Increasing evidence has documented that the highest risk is posed 
during early and postnatal development while forming organ and neural systems 
[9]. Sometimes, epigenetic changes (DNA methylation or acetylation) or histone 
modifications are also involved in endocrine disruption [10].
EDCs are highly heterogeneous and can be classified based on their origin: 
Industrial and household chemicals (dioxins, phthalates, polychlorinated biphenyls 
(PCBs), alkylphenols, plasticizers, fire retardants), agricultural (insecticides, 
pesticides, herbicides, fungicides, phytoestrogens), residential {bisphenol A (BPA), 
polybrominated biphenyls (PBBs), phthalates} and some pharmaceuticals agents 
{parabens, diethylstilbestrol (DES)} [3, 5, 11]. Heavy metals such as lead, mercury, 
cadmium, and arsenic are also included in the EDCs long list (Figure 1) [10, 12]. 
According to the Stockholm Convention (2001), both production and usage of 
persistent organic pollutants (POPs) was restricted [13]. Guidelines for a list of 
chemicals were developed to store and eliminate them, which was happened in 2008 
and 2014 [14]. Initially, almost twelve POPs were designated as “dirty dozen” due to 
their severe adverse effects on humans and the ecosystem. Hence, their production 
and use were banned. The dirty dozen included industrial chemicals, pesticides, 
and by-products such as aldrin, chlordane, dieldrin, endrin, dichlorodiphenyltri-
chloroethane (DDT), heptachlor, mirex, toxaphene, PCBs, hexachlorobenzene, 
polychlorinated dibenzo-p-dioxins, and polychlorinated dibenzofurans [9].
2. Human exposure and route of entry of EDCs
Endocrine-disrupting chemicals may exhibit various exposure routes to enter 
the human body. Generally, inhalation (e.g., Plasticizers), dietary intake (e.g., 
Foods), dermal absorption (e.g., Cosmetics), and embryonic exposure (e.g., 
Transfer from mother) represent the main exposure pathways (Figure 2) [5, 15]. 
Following any of these pathways, EDCs may enter the food chain and accumulate 
in different tissues [16]. Mostly EDCs are highly lipophilic in nature and hence 
accumulate in the adipose tissue having a long half-life. These aforementioned 
Figure 1. 
Sources and examples of EDCs.
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features explain the exact reasons for being the accumulation of EDCs for years in 
the adipose tissue. Humans and other top predators are at the top of the food chain. 
Hence, due to bioaccumulation and biomagnification, they may store many EDCs, 
ultimately leading to various adverse consequences. Even lifelong exposure or fetal 
or neonatal stage exposure may bring about cumulative or additive or synergic 
effects. Therefore, the timing of exposure is of utmost importance in evaluating 
adverse effects on the endocrine system.
Endocrine disruptors such as dioxins, PCBs, perfluorinated compounds, and 
DDT are commonly found in pesticide-contaminated soil or groundwater or indus-
trial waste quickly enter the human body via oral consumption of food or water. 
Some of the commonly used EDCs (DDT, vinclozolin, pyrethroids, chlorpyrifos) 
in households, agriculture, or public disease vector control may come in contact 
with human skin or through inhalation. In addition to this, cosmetics, personal care 
products, sunscreens, medications (triclosan, paraben, phthalates) that we apply 
on our skin are also responsible for their uptake into our body [17]. Professional 
workers using fungicides, pesticides, and chemicals are most prone and at high risk 
of EDCs exposure.
3. HPG axis: the central regulator
The mammalian reproductive cycles are mainly controlled by an intricate play 
between hypothalamus pituitary and gonads [18]. The hypothalamic Gonadotropin-
Releasing Hormone (GnRH) neurons regulate reproductive functions in all verte-
brates. The hypothalamic–pituitary-gonadal (HPG) axis plays a crucial role in the 
normal development of the reproductive system by controlling the ovarian as well 
as uterine cycles in females and also spermatogenesis in males [18, 19]. In response 
to GnRH release from the hypothalamus, pituitary gonadotropic cells synthesize 
and release Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH), 
which travel via the bloodstream to the target organs. LH and FSH are essential 
as regulators of both ovarian and testicular function. In males, LH stimulates 
Figure 2. 
Route of entries of EDCs.
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testicular Leydig cells to synthesize and secrete testosterone, which in turn main-
tains spermatogenesis in Sertoli cells through its paracrine action and exerts sexual 
and anabolic actions. While FSH acts on Sertoli cells to produce androgen-binding 
protein, which is critical for spermatogenesis initiation and ultimately augments 
sperm production [20]. In females, the production of GnRH, LH, and FSH via the 
HPG axis are similar, but the actions of these hormones are different. LH and FSH 
exert their function on the ovaries to promote follicular maturation, ovulation, 
corpus luteum development, and estrogen and progesterone production [21, 22]. 
These hormones also have a role in regulating the uterine (menstrual) cycle to 
prepare for ovulation and embryo implantation [23]. These gonadal steroid hor-
mones secreted by ovaries and testis can inhibit GnRH’s hypothalamic synthesis 
via a feedback loop, hence playing a vital role in regulating reproductive function. 
In most mammals, 17β- Estradiol, testosterone, and progesterone are the primary 
estrogen, androgen, and progestin, respectively, and each of their receptors are 
expressed abundantly in the hypothalamus (Figure 3) [24].
4. Molecular mechanisms of EDCs
It is widely known that EDCs molecule, either natural or synthetic, follows the 
classical mechanism of action to mimic or interfere with the action of an endocrine 
regulated network of vertebrates. This interference can happen through different 
Figure 3. 
Regulation of HPG axis.
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mechanisms, either through genomic or non-genomic actions. So before under-
standing the mechanism of endocrine disruption, we must have a clear picture of 
the endocrine system that relies on the synthesis and release of hormones from vari-
ous endocrine glands and its transport via the bloodstream to the required distant 
cells and tissues [25]. This process involves complex interacting signaling pathways 
and hormone receptors to control normal body function. Estrogen receptors (ERs) 
regulate the transcription of their target genes via multiple pathways, either directly 
or indirectly. Any changes in ER signaling may lead to adverse consequences such 
as hormone-dependent cancer, abnormal fetal growth and development, altered 
metabolism, and sometimes impaired fertility. Although the effect of EDCs is not 
limited to only the ligand-dependent ER signaling pathway, it is the best-studied 
of ER targeted endocrine disruption. ER in response to ligand signals through both 
genomic as well as a non-genomic pathway. Briefly, ER mediates its signal in the 
genomic pathway by binding directly to estrogen-responsive elements (ERE) or 
indirectly through coactivators such as SP-1 or AP-1. Although the best well-studied 
nuclear receptor cofactors belong to the p160 family of coactivators (e.g., SRC-1, 
SRC-2, and SRC-3) but the cofactor complex that mediates ER signaling is more 
complicated.
The non-genomic pathway has a rapid response as within minutes of ligand 
binding, signal transduction occurs. During estrogen ligand, a G-protein coupled 
receptor (GPCR-30) activates and mediates the signal independent of ERs 
and stimulates cAMP production, fluctuates intracellular calcium, or lead to 
MAPK or PI3K signaling cascades events. BPA and DES are extensively studied 
EDCs, which also induce rapid estrogen signaling via the non-genomic pathway 
(Figure 4).
Figure 4. 
Genomic and non-genomic pathway of estrogen signaling.
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Steroid hormones are a group of lipophilic molecules that regulate a wide variety 
of physiological functions starting from fetal life to adulthood [26]. All these steroid 
hormones are biosynthesized from cholesterol, including glucocorticoids, mineralo-
corticoids, progestin, estrogen, and androgen, regulating sexual and reproductive 
development. Steroidogenic enzymes involved in the steroid hormone biosynthe-
sis pathway are considered as the crucial targets for EDCs action. For example, 
Researches have demonstrated that exposure of Nonylphenol (NP) concentration 
10−4 to 10−1 M at several ages with multiple rat generations (N = 3-4 per group) can 
decrease P450scc activity in testes [27]. Phthalates exposure, which consists of a 
particular class of pesticides, inhibits testosterone synthesis in Leydig cells due to 
direct CYP17 inhibition and hence exerts anti-androgenic effects [28]. Furthermore, 
BPA of different concentrations (10−8 to 10−4 M) have been shown to inhibit the 
enzymatic activity of 3β-HSD, CYP17A1, and 17β-HSD3 in a dose-dependent manner 
in both human and rat testicular microsomes [29]. EDCs exposure also inhibits the 
activity of 5-α reductase, which is one of the main enzymes involved in dihydrotes-
tosterone production from testosterone and hence in the regulation of masculiniza-
tion of the external genitalia and the prostrate [30].
Aromatase (cyp19a) is known as the potential target action of EDC, and any 
modulation in its expression and function alters the estrogen production rate and 
hence disrupts the estrogen-dependent process [31]. A study suggested that BPA 
exposure in rat testis R2C Leydig cells stimulate aromatase activity and is correlated 
with upregulation in COX-2 in R2C cells [32].
In addition to steroidogenic enzymes and hormone metabolism, EDCs are 
also known to affect hormone-related receptor and their expression. EDCs, due 
to their similarity in structural features with the endogenous estrogen hormones, 
bind easily with the estrogen receptors and thus modify estrogen-responsive gene 
expression. EDCs that display binding with ERs include industrial bisphenolics, 
pharmaceutical chemicals, phytoestrogens, and organochlorine pesticides. 
Methoxychlor (MTX) and DDT are examples of organochlorine pesticides that 
exhibit estrogenic activity through binding with ERα and ERβ ligand-binding 
domains [33]. Thus, as reported, both pesticides adversely affect the female repro-
ductive trait by impairing normal follicle development and stimulating uterine 
proliferation [34]. The insecticide endosulfan has a similar estrogenic activity 
that causes ovarian regression in both in vitro and in vivo studies [35]. Endosulfan 
competes with estradiol for interacting with the estrogen receptor but with lower 
affinity and, in turn, affects sex-specific gene expression [36]. Endosulfan can 
also affect the male reproductive system by decreasing the gene expression of 
testis-related transcription factors (sox9a and wt1) [37]. BPA possesses a binding 
affinity for ERs subtypes (ERα and ERβ) and is categorized as a prototypical non-
steroidal ER [38].
It is also important to note that EDCs exhibit multiple hormone-binding actions 
regardless of their binding to hormonal receptors. For instance, DDT is an agonist 
for the estrogen receptor, but one of the metabolites of DDT shows anti-androgenic 
activity [39]. Similarly, BPA shows estrogenic and androgenic activity but exhibits 
an antagonist nature for thyroid hormone [40, 41].
5. Effect of EDCs on female reproductive system
The female reproductive system’s development is credited to folliculogenesis, 
where adverse biological effects of EDCs can be observed. The primordial follicles 
finally become primary, pre-antral, and the antral follicle. Environmental toxicants 
such as BPA, MTX, and phthalates may interfere at any developmental stage of the 
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aforementioned antral follicle growth and hinder the reproduction, sometimes 
causing infertility. BPA exposure during in-vitro studies has been shown to inhibit 
mouse antral follicle development [42]. Follicle growth is dependent on the prolif-
eration of theca and granulosa cells [43].
Estrogens are well-known as the gatekeepers of the female reproductive 
system. The sudden increase during puberty opens the gate to enter the reproduc-
tive life, and at menopause, the gate gets closed due to their decreased level. Thus, 
the environmental chemicals that behave as agonists or antagonists to estrogen 
hormone may play a role in precocious puberty, polycystic ovary syndrome, 
delay in menopause, and premature ovarian failure [44]. Increased growth of the 
endometrium and breast cancer are some of the unwanted side effects in females 
that can also occur due to EDCs exposure.
5.1 Puberty and breast development
The growing evidence of EDCs affecting puberty or early breast development 
in the female has dramatically increased. It has been observed from the studies 
that the age of menarche has been decreased from 16-17 years to less than 13 years 
[5]. The increased estrogen-to-androgen ratio due to overexpression of aromatase 
activity has been shown to cause early or premature breast development and 
sometimes gynecomastia in boys [45, 46].
5.2 Breast cancer
Breast cancer is a multifactorial disease [47] and mainly results from time-
related complex interactions between internal and external factors [48]. Although 
endogenous estrogen has a role in breast tumor genesis, but estrogen-mimicking 
exogenous EDCs such as PCBs, BPA, DES, and phthalates have substantial impacts 
on breast development during the perinatal period and also on carcinogenesis in 
adults [48]. Studies have reported that women with prenatal exposure to DES, 
a synthetic estrogen, have an increased risk of breast cancer in their later age 
(≥40 years) [49]. Perinatal BPA exposure at environmentally relevant concentra-
tion alters breast development in both outbred mice and rats. The mode of action 
of estrogen-mimicking EDCs is two-fold; firstly, their action is on the prolifera-
tion of stromal cells and, secondly, concerned with epigenetic mechanisms [50]. 
EDCs affect the stromal cells by interfering with the estrogen signal pathway. 
HOXB9 is a homeobox-containing gene that plays a vital role in mammary gland 
development and is associated with breast cancer. Reports have shown that BPA 
competes with ER and leads to activation of this gene through histone modifica-
tion and acetylation [50].
5.3 Uterine disease
Endometriosis and uterine fibroids are the most common female reproductive 
disorders, having an estimated combined incidence of up to 70% of women. Due 
to their cryptic nature, many women with either endometriosis or fibroids may 
remain asymptomatic or undiagnosed and are more likely caused due to environ-
mental endocrine-active compounds. For instance, non-human primates exposed 
to environmental contaminant TCDD (dioxin) have a higher endometriosis rate. 
The onset of fibroids occurs mainly after puberty, and this benign uterine tumor 
regresses after menopause. Fibroids are found to be more sensitive to the estrogen 
effect [51]. Hence, due to its dependency on estrogen for its growth, the role of 
environmental estrogen-mimicking EDCs in fibroid disease should be considered. 
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Several reports have documented that developmental exposure to EDCs such as 
MTX, PCBs, DDT, DES have been implicated in the development of uterine fibroid 
disease [52].
5.4 Primary ovarian failure (POF)
About 1% of the female population under 40 years of age suffers from POF, 
leading to other comorbidities related to reproductive disorder or early menopause 
[53]. The possible mechanism of POF development includes premature activation 
of the follicle, blockage of follicle maturation, and acceleration of apoptosis. Several 
cases of POF have been reported, and EDCs might have some association with 
its occurrence. Many EDCs are related to multi-oocyte follicles (MOF) mediated 
by EDCs-induced ERβ agonist action. Administration of BPA (0.1-1,000 μg/kg) 
to pregnant mice between the critical periods of differentiation (9th-16th day), 
ovarian cysts appeared in adulthood, which was significantly more in number in 
the group that received 1 μg/kg BPA [54]. Paraben is another example of EDC that 
affects folliculogenesis by stimulating anti-mullerian hormone (AMH) mRNA 
expression and inhibits the early stage of ovarian follicle in newborn rats [44]. 
Similarly, MTX inhibits folliculogenesis and increases AMH expression in the 
pre-antral and early-antral follicles [55]. Recent studies have demonstrated that 
neonatal exposure of DES (3 μg/kg) induces MOF [56].
5.5 Menstrual irregularity
Studies have shown that fetal and neonatal exposure to EDCs exposure in 
humans may interfere with hormonal regulation and result in irregular or long 
cycles of the menstrual cycle [57]. The irregularities in the menstrual cycle may 
ultimately reduce fecundity. In-utero exposure to estrogenic compounds such as 
phytoestrogens or BPA in an animal model such as adult mice increases estrous cycle 
duration. In comparison, perinatal exposure to BPA results in early suspension and 
irregular cyclic activity [58] that are likely due to a change in LH secretion’s hypo-
thalamic control and ovulation [59].
5.6 Polycystic ovarian syndrome (PCOS)
This disease is a more prevalent endocrine disorder in women, characterized 
by anovulation and hyperandrogenism. This syndrome is associated with a higher 
Reference Chemicals Organism Results
[5] EDCs Human Decreased age of menarche
[54] BPA Mice Induces PCOS
[44] Paraben Rats Inhibit early stage of ovarian follicle
[55] MTX Rats Increase the expression of AMH in the pre-antral and 
early-antral follicles
[56] DES Mice Induces MOF
[57] PBD, PCB Human Irregular menstrual cycle
[58] BPA Human Irregular menstrual cycle
[60] BPA Human Development of PCOS
Table 1. 
A summary of the remarkable studies on effects of EDCs on female reproductive systems.
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prevalence of obesity, insulin resistance, and other metabolic comorbidities. 
However, this disease’s pathogenesis is still not exact, but evidence shows that 
genetic and environmental factors such as EDCs may contribute to PCOS’s clinical 
development. BPA, a well-known estrogenic and androgenic endocrine disruptor, 
acts differently to interfere in reproductive functions. In vitro studies have shown 
that BPA exposure in rat ovarian thecal interstitial cells increases testosterone 
synthesis.
In contrast, in male rats, BPA competes with androgens to bind on sex 
hormone-binding globulin (SHBG), increasing serum-free androgen level. BPA 
exposure during neonatal conditions could lead to PCOS development. Besides, the 
estrogenic effect of environmental contaminant BPA enhances the risk of hyper-
tension, type2 diabetes, and dyslipidemia (Table 1) [60].
6. Effect of EDCs on male reproductive system
A large number of studies reported the toxic effects of environmental contami-
nants on male reproductive health. Numerous EDCs present in our environment 
may have a causative role in testicular dysgenesis syndrome (TDS) in humans. 
Impaired spermatogenesis, decrease in semen quality, sperm anomalies, hypospa-
dias, ectopic testes, cryptorchidism, and testicular cancer are important risk factors 
responsible for the symptoms of developmental disorder, TDS and ultimately caus-
ing male infertility. During the normal condition, a functional hormonal feedback 
loop regulates and ensures proper homeostasis. Sometimes, at the time of sexual 
development, exposure to certain chemicals may disrupt this tightly-regulated 
hormonal balance. Even short-term exposures can also have adverse effects and may 
cause infertility [61].
6.1 Semen and sperm quality
Semen parameters are used to measure sperm quality and are sometimes con-
sidered indicators of compromised male fertility [62]. Recently, the adverse health 
effects of the male reproductive system, especially due to BPA’s estrogenic property, 
have attracted much more attention. BPA is well-known as a testicular toxicant in 
animal models as it results in decreased sperm quality and motility, oxidative stress 
increases, and alters steroidogenesis [42]. Few studies were done in occupationally 
exposed men, and infertile men have also reported a negative correlation between 
semen quality and urinary BPA levels. The underlying mechanism may be related to 
increased oxidative stress and disruption in the steroidogenesis pathway [63].
Functional anomalies of sperm may play a crucial role in male infertility. As 
reported, in comparison with fertile controls, infertile men have higher seminal 
reactive oxygen species (ROS) levels; hence studies have suggested ROS might have 
some role in male infertility. Sperm cells do not contain any cytoplasmic defense 
enzymes that can serve as ROS scavengers. Therefore, a change in lipid peroxidation 
(LPO) impairs the plasma membrane fluidity and integrity and ultimately leading 
to loss of sperm function and movement. Exposure to carbaryl causes low LPO 
concentrations with an increase in ROS and hence may be associated with altered 
semen quality, especially sperm motility [64].
Furthermore, BPA was also associated with DNA damage, lower sperm count, 
abnormal sperm morphology, and motion [65]. Regarding the hormonal level, BPA 
caused higher FSH, lower inhibin B level, and a lower estradiol-to-testosterone 
ratio [65]. In a study comprising 375 fertile men, BPA was further associated with 
decreased free androgen index and higher testosterone level [66].
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Mixtures of polychlorinated dibenzo-p-dioxins (PCDDs) and dibenzofurans 
(PCDFs), shortly named ‘dioxins’, produce adverse health effects reported in 
several studies. For instance, A study have reported a potential association between 
chemical dioxins exposure and semen quality. Exposed men have a higher percent-
age of oligospermia and abnormal sperm morphology [67].
6.2 Testicular cancer, cryptorchidism and hypospadias
Testicular cancer is the most common disorder found in most young men in 
many countries. A worldwide trend can be observed towards the increasing number 
of testicular cancers. Exposure to environmental contaminants such as phthalates 
causes low semen quality, which ultimately may coincide with the development 
of cryptorchidism, testicular cancer, and hypospadias. The combination of the 
three aforementioned disorders of the male reproductive system can be termed as 
“so-called” testicular TDS. Experimental and epidemiological evidence has dem-
onstrated that TDS is an outcome of interference during embryonal physiological 
programming and gonadal development in fetal life [68, 69]. EDCs such as phthal-
ates, vinclozolin, polybrominated diphenyl ethers (PBDE), and acetaminophen 
have shown a significant etiopathogenetic role towards the onset of TDS [10]. 
Despite all these studies, the exact contribution and mechanism behind pesticide 
and EDC exposure towards testicular cancer development have not been elucidated 
to date. However, genetic and environmental factors have been documented for the 
reduced sperm count and disease formation (Table 2) [70].
7. Effect of EDCs on fetal and neonatal stages
Although adult exposure towards EDCs is an essential factor, the duration of 
EDCs exposure in fetus and neonate is also of primary concern. It plays a crucial 
factor in determining its fate. For instance, Due to early EDCs exposure, develop-
ment is compromised because EDCs at the neonatal stage are extremely sensitive 
and affect the same brain regions, circuits, hormone-sensitive pathways, and 
receptors like the endogenous hormones. Such effects have been reported for 
several EDCs across various species and have profound detrimental consequences 
in developing organisms compared to adults [71, 72]. The extreme sensitivity of 
Reference Chemicals Organism Results
[42] BPA Human Decreased sperm quality and motility, altered 
steroidogenesis
[63] BPA Rat Disrupted steroidogenic pathway
[64] Carbaryl/naphthalene 
and chlorpyrifos
Human Altered semen quality, sperm motility
[65] BPA Human Lower sperm count, abnormal sperm 
morphology, higher FSH, lower inhibin B level, 
lower estradiol-to-testosterone ratio
[67] Dioxin Human Higher percentage of oligospermia and 
abnormal sperm morphology
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developing fetus and neonate has been described briefly in a chapter titled “The 
Fragile Fetus” by Howard Bern [73]. All those protective mechanisms present 
in adults like DNA Repair Mechanism, detoxifying enzymes, liver metabolism, 
competent immune system, and the blood–brain barrier are not fully developed or 
functional during the fetus or neonatal stage. Even the metabolic rate of develop-
ing organisms is much higher than adults, which may be the cause of increased 
toxicity due to environmental contaminants exposures. Numerous reports have 
documented that developmental exposure to EDCs can lead to various adverse 
effects in adults and sometimes cause tumors in endocrine tissues and adverse 
reproductive consequences in males and females [74]. Pieces of evidence have 
stated that exposure to environmental triggers such as EDCs during critical stages 
in fetal sex differentiation and development in utero disrupts reproductive organ 
differentiation and sometimes leading to intersex variation (IV) conditions. IV 
can be defined as a morphological and physiological anomaly where an individual 
is born with a congenital condition such as ambiguous genitalia/ hermaphrodite 
or pseudohermaphroditism etc. [75]. The most evident case for endocrine disrup-
tion in utero that may lead to the onset of adult disease in the newborn is prenatal 
exposure to DES. Between 1958 and 1976, doctors prescribed synthetic estrogen to 
pregnant women to prevent miscarriages and premature delivery. It was almost a 
4-6million pregnancies that were treated with DES in the US alone. In 1971, DES 
was linked with a rare gynecologic neoplasm in female offspring of DES-exposed 
pregnancies [76]. Subsequent studies have documented the link between mater-
nal treatment with DES and cervicovaginal cancer in DES-exposed daughters, 
usually in their late teens or early 20s. This was the first evidence of transplacental 
carcinogenesis in humans [51]. Additionally, the offspring of DES-exposed 
mothers also had functional and anatomical abnormalities of the uterus and 
fallopian tubes.
8. Effect of EDCs on epigenetic regulations
The epigenetic modifications can be defined as “heritable and reversible 
chemical modifications of chromatin, resulting in an adjustment of its activ-
ity without a change in the underlying DNA sequence [77]. Notably, epigenetic 
effects are mediated by those transcription factors that enhance or repress any 
specific genes’ transcription. The well-studied epigenetic modifications include 
DNA methylation at the cytosine base, post-translational modification of histone 
proteins (histone acetylation and deacetylation), and non-coding RNAs. Post-
translational modification of histone protein at specific amino acids, for instance, 
lysine, may alter chromatin’s structure and function. Generally, acetylation of 
histone at lysine position results in activation of transcription by relaxing the 
chromatin structure, while methylation of lysine depending on the position may 
lead to activation or repression of gene expression. However, deacetylation may 
lead to transcriptional repression or silencing of the genes. Non-coding RNA is the 
transcript of gene sequences that do not code for proteins but regulate its expres-
sion in a cis or trans manner mainly involved in some unique functions such as 
genomic imprinting, X-chromosome inactivation, and developmental patterning 
and differentiation [70].
The most commonly studied epigenetic mechanism is the EDCs effect on the 
enzymes that regulate epigenetic patterning, especially the DNA methyl trans-
ferase (DNMTs). The endocrine disruptor, Vincolozolin, an androgen receptor 
antagonist, induced increased expression of dnmt mRNA expression in an in-vivo 
model through an AR-mediated pathway [78]. Studies have reported that DES 
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can activate immediately early genes such as c-myc, c-jun, c-fos, and lactoferrin, 
which are upregulated during childhood [53]. This activation is possible due to 
the promoter region’s hypomethylation of the lactoferrin gene in the adult uterus 
[79]; however, no such patterns were observed when an adult was exposed during 
adulthood at the same interval. Upon prenatal exposure to DES, tet1 mRNA 
expression was significantly decreased in mouse uterus and the same response 
found in zebrafish gonads upon BPA exposure [21, 80, 81]. Exposure to EDCs 
during development could alter the perturbation of the genome’s epigenetic 
patterning and may result in adult-onset disease. The epigenetic changes in the 
ovary have been reported for the organochlorine pesticide MTX. In a study, MTX 
exposure from embryonic to postnatal days caused hypermethylation in the 
ERβ promoter regions by performing DNA methylation analysis using bisulfite 
sequencing and methylation-specific PCR [82].
9. Conclusion
Research over the last few years exploited the adverse effects of EDCs, which 
were lesser-known. Some of them were heavily used in the past decade, and some 
are just enlisted their names on the list of ‘emerging pollutants,’ and altogether, 
they are creating an unhealthy world to live on for us as well as for other animals. 
This chapter summarizes the harmful effects of EDCs exposure on male and female 
reproductive physiology and also elucidates the possible mechanism of actions. 
Though numerous articles and reports regarding these EDCs’ toxicological effects 
are available today, still very little is known about their mechanism of action in our 
body. The poor understanding of their underlying mechanism in hampering one’s 
endocrine system keeps us at bay to fight against it. Be it your morning toothpaste or 
your hair nourishing shampoo, and you cannot escape from the exposure of EDCs 
in your daily life. Even processed foods have EDCs in them. Scientists predict that 
there are many more of this kind of chemical whose effects are yet to be evaluated. 
Many countries’ government bodies are actively monitoring the situations and tak-
ing actions accordingly alongside the scientists who are tirelessly working to find out 
ways to nullify the adverse effects. We can follow the recent resources available in 
the public domains and choose a healthy way to live to minimize the EDCs exposure. 
Extra care should be taken in choosing your packaged food materials, cosmetics, 
plastic made equipment, cooking utensils, fruits, and vegetables. Finally, emphasis 
should be on the betterment of regulatory systems for introducing new, untested 
chemicals alongside the continuous use of chemicals already proved for being EDCs. 
Utmost care should be taken for pregnant women and infants, who are most vulner-
able to EDCs exposure.
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